Cancer and Coronary Heart Disease ― To Bleed or Not to Bleed, That Is the Question ―
Open Access
- 25 May 2021
- journal article
- editorial
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 85 (6), 847-849
- https://doi.org/10.1253/circj.cj-21-0174
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesThis publication has 16 references indexed in Scilit:
- Managing the competing risks of thrombosis, bleeding, and anticoagulation in patients with malignancyBlood Advances, 2019
- Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding RiskEuropean Heart Journal, 2019
- Percutaneous coronary intervention in cancer patients: a report of the prevalence and outcomes in the United StatesEuropean Heart Journal, 2018
- Arterial thrombosis and cancer: the neglected side of the coin of Trousseau syndromeHaematologica, 2018
- Prediction of Thrombotic and Bleeding Events After Percutaneous Coronary Intervention: CREDO‐Kyoto Thrombotic and Bleeding Risk ScoresJournal of the American Heart Association, 2018
- Risk of Arterial Thromboembolism in Patients With CancerJournal of Invasive Cardiology, 2017
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseThe New England Journal of Medicine, 2017
- Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trialsThe Lancet, 2017
- Cancer and Venous Thromboembolic Disease: A ReviewThe Oncologist, 2017
- Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting StentsJournal of Invasive Cardiology, 2016